**Core Concept**
Reversible monoamine oxidase inhibitors (MAOIs) are a type of antidepressant medication that selectively and reversibly inhibit the enzyme monoamine oxidase, which is responsible for breaking down monoamine neurotransmitters such as serotonin, norepinephrine, and dopamine. This inhibition leads to increased levels of these neurotransmitters in the synaptic cleft, resulting in improved mood and reduced symptoms of depression.

**Why the Correct Answer is Right**
Reversible MAOIs, such as moclobemide and pirlindole, selectively inhibit MAO-A, the isoform primarily responsible for metabolizing serotonin and norepinephrine. This selective inhibition allows for a safer and more targeted approach to increasing monoamine levels, reducing the risk of hypertensive crises associated with non-selective MAOIs. The reversible nature of these inhibitors also allows for quicker recovery of MAO activity in case of overdose or adverse effects.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it does not specify the type of MAOIs. Non-selective MAOIs, such as phenelzine and tranylcypromine, are irreversible and can cause significant side effects.
* **Option B:** This option is incorrect as it is a type of selective serotonin reuptake inhibitor (SSRI), which works by inhibiting the reuptake of serotonin rather than inhibiting MAO.
* **Option C:** This option is incorrect as it is a type of tricyclic antidepressant, which works by blocking reuptake of norepinephrine and serotonin.

**Clinical Pearl / High-Yield Fact**
Reversible MAOIs are a good option for patients with depression who have a history of hypertension or cardiovascular disease, as they are less likely to cause hypertensive crises.

**Correct Answer:** C.